Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
- 1 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (2), 556-561
- https://doi.org/10.1161/01.str.0000196942.84707.71
Abstract
Brain hemorrhage after ischemic stroke is a serious complication of treatment; however, its pathology is poorly understood. A classification based on brain imaging may help to better understand and avoid causal factors. Review of the results of controlled randomized trials and the available literature. Hemorrhagic infarctions have no impact on clinical outcome and are probably not associated with the thrombolytic itself and the type of reperfusion strategy. They are associated with the extent of ischemic damage and most probably to an ischemic vasculopathy. Parenchymal hematomas are often clinically relevant. Their incidence is affected by the thrombolytic itself, the type, and probably the time point of reperfusion strategy. The loss of hemostatic control seems important in their pathogenesis. Extraischemic hematomas (remote from the infarct), unique or multiple, suggest pre-existing brain pathology, especially cerebral amyloid angiopathy. The radiological description of 3 different types of brain hemorrhage is useful to better understand the specific pathology and the impact on clinical outcome. It may help to avoid clinically relevant brain hemorrhages.Keywords
This publication has 27 references indexed in Scilit:
- The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)Stroke, 2005
- Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activatorJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Early Fibrinogen Degradation Coagulopathy Is Predictive of Parenchymal Hematomas in Cerebral rt-PA ThrombolysisStroke, 2004
- Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRICerebrovascular Diseases, 2003
- Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical PracticeStroke, 2003
- Selection of Acute Ischemic Stroke Patients for Intra-Arterial Thrombolysis With Pro-Urokinase by Using ASPECTSStroke, 2003
- Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen ActivatorStroke, 2002
- Thrombolysis-Related Hemorrhagic InfarctionStroke, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intracerebral hemorrhage related to cerebral amyloid angiopathy and T‐PA treatmentAnnals of Neurology, 1991